Literature DB >> 12526173

In vivo infection of mice by replication-competent MLV-based retroviral vectors.

Estanislao Bachrach1, Mogens Duch, Mireia Pelegrin, Hanna Dreja, Finn Skou Pedersen, Marc Piechaczyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12526173     DOI： 10.1385/1-59259-304-6:343

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  3 in total

1.  Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.

Authors:  Chien-Kuo Tai; Wei Jun Wang; Thomas C Chen; Noriyuki Kasahara
Journal:  Mol Ther       Date:  2005-11       Impact factor: 11.454

2.  Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.

Authors:  Shuji Kubo; Kazunori Haga; Atsuko Tamamoto; Donna J Palmer; Philip Ng; Haruki Okamura; Noriyuki Kasahara
Journal:  Mol Ther       Date:  2010-08-31       Impact factor: 11.454

3.  Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.

Authors:  Matthias Paar; Sonja Schwab; Doris Rosenfellner; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.